TY - JOUR
T1 - The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1
AU - Ballester-Lopez, Alfonsina
AU - Linares-Pardo, Ian
AU - Koehorst, Emma
AU - Núñez-Manchón, Judit
AU - Pintos-Morell, Guillem
AU - Coll-Cantí, Jaume
AU - Almendrote, Míriam
AU - Lucente, Giuseppe
AU - Arbex, Andrea
AU - Magaña, Jonathan J.
AU - Murillo-Melo, Nadia M.
AU - Lucia, Alejandro
AU - Monckton, Darren G.
AU - Cumming, Sarah A.
AU - Ramos-Fransi, Alba
AU - Martínez-Piñeiro, Alicia
AU - Nogales, Gisela
PY - 2020
Y1 - 2020
N2 - The number of cytosine-thymine-guanine (CTG) repeats ('CTG expansion size') in the 3'untranslated region (UTR) region of the dystrophia myotonica -protein kinase (DMPK) gene is a hallmark of myotonic dystrophy type 1 (DM1), which has been related to age of disease onset and clinical severity. However, accurate determination of CTG expansion size is challenging due to its characteristic instability. We compared five different approaches (heat pulse extension polymerase chain reaction [PCR], long PCR-Southern blot [with three different primers sets-1, 2 and 3] and small pool [SP]-PCR) to estimate CTG expansion size in the progenitor allele as well as the most abundant CTG expansion size, in 15 patients with DM1. Our results indicated variability between the methods (although we found no overall differences between long PCR 1 and 2 and SP-PCR, respectively). While keeping in mind the limited sample size of our patient cohort, SP-PCR appeared as the most suitable technique, with an inverse significant correlation found between CTG expansion size of the progenitor allele, as determined by this method, and age of disease onset (r = −0.734, p = 0.016). Yet, in light of the variability of the results obtained with the different methods, we propose that an international agreement is needed to determine which is the most suitable method for assessing CTG expansion size in DM1
AB - The number of cytosine-thymine-guanine (CTG) repeats ('CTG expansion size') in the 3'untranslated region (UTR) region of the dystrophia myotonica -protein kinase (DMPK) gene is a hallmark of myotonic dystrophy type 1 (DM1), which has been related to age of disease onset and clinical severity. However, accurate determination of CTG expansion size is challenging due to its characteristic instability. We compared five different approaches (heat pulse extension polymerase chain reaction [PCR], long PCR-Southern blot [with three different primers sets-1, 2 and 3] and small pool [SP]-PCR) to estimate CTG expansion size in the progenitor allele as well as the most abundant CTG expansion size, in 15 patients with DM1. Our results indicated variability between the methods (although we found no overall differences between long PCR 1 and 2 and SP-PCR, respectively). While keeping in mind the limited sample size of our patient cohort, SP-PCR appeared as the most suitable technique, with an inverse significant correlation found between CTG expansion size of the progenitor allele, as determined by this method, and age of disease onset (r = −0.734, p = 0.016). Yet, in light of the variability of the results obtained with the different methods, we propose that an international agreement is needed to determine which is the most suitable method for assessing CTG expansion size in DM1
KW - CTG expansion size
KW - Myotonic dystrophy type 1
KW - Long PCR
KW - Small pool-PCR
KW - Age of disease onset
U2 - 10.3390/genes11070757
DO - 10.3390/genes11070757
M3 - Article
C2 - 32645888
SN - 2073-4425
VL - 11
JO - Genes
JF - Genes
ER -